On Tuesday, November 5, the Federal Circuit voted 6-4 to deny a request for en banc rehearing in Fresenius vs. Baxter. The court decision in July held that “cancellation of a patent on re-examination can wipe out an infringement judgment.” Finnegan partner James R. Barney told Law360 “The en banc court split dramatically and the dissent uses language flagging this as an important constitutional issue,” he said. “It has all the ingredients to have as a good a chance as any of being taken up by the Supreme Court.”
Barney also said, “What makes this case stand out is the degree to which the district court decision is perceived to be final,” where even a final court decision that the patent is valid and infringed is not final enough. He noted interesting implications in light of new America Invents Act proceedings, adding, “This is a very important case for the bar because of the new post-grant review procedures that are in place and that new emphasis by Congress and the PTO on using those procedures. Patent litigation is high stakes and litigants look for any opportunity to press their advantage.”
Commentary
Patent Strategy Could Shape Financing, Valuation and Risk in Offshore Energy Projects
June 30, 2026
Award/Ranking
Finnegan’s European Practices and Attorneys Highlighted in 2026 Managing IP Rankings
June 25, 2026
Press Release
BMW Obtains Preliminary Injunction Against Zync; Federal Court Orders Zync to Halt ITC Trade Secret
June 23, 2026
Award/Ranking
Six Finnegan Partners Recognized in the 2026 Lawdragon 500 Leading Global IP Lawyers
June 22, 2026
Commentary
U.S. Judge Rules Forum-Selection Clause Bars Zync from Pursuing ITC Trade Secret Case
June 15, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.